Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection.

This study shows that the use of PPIs could impact COVID-19 clinical presentation toward more gastrointestinal manifestations. Further studies investigating the link between other acid suppression medications and COVID-19 manifestations and severity should be carried out.